OCUPHIRE PHARMA, INC.Capital on Demand Sales Agreement • March 11th, 2021 • Ocuphire Pharma, Inc. • Pharmaceutical preparations • New York
Ocuphire Pharma, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with JonesTrading Institutional Services LLC (the “Agent”), as follows:
